Join our pharma IP experts as they analyse the most important developments in EPO case law from the past year. This webinar will provide practical advice, key take-home messages, and strategic insights for your patent practice.
Topics will include:
- EBA Decisions: Unpacking the practical impact of G 1/23 (prior use), G 1/24 (claim interpretation), and G 2/24 (late interveners) on pharma and biotech cases.
- Second medical use: Strategies for navigating the post-G 2/21 landscape.
- Antibody claims: An update on the latest EPO positions on functional and epitope claims.
- Formulation & manufacturing IP: Key case law developments for formulation, dosage, and manufacturing patents.
- Global implications: How may EPO case law developments impact your global IP strategy.
- AI in biotech: The growing impact of artificial intelligence on pharma drafting and prosecution.
- Horizon Scan: Key trends and decisions to watch for in 2026.
Who should attend:
- Patent attorneys and IP professionals (in-house & private practice)
- IP portfolio managers
- Tech-transfer professionals
Speaker: Rose Hughes
